Literature DB >> 12139427

Improved methods for typing nontypeable isolates of group B streptococci.

Jeffrey A Benson1, Aurea E Flores, Carol J Baker, Sharon L Hillier, Patricia Ferrieri.   

Abstract

Group B streptococci (GBS) are classified by capsular polysaccharide (CPS) type and by cell surface-expressed proteins (c and R). Isolates lacking detectable CPS are considered nontypeable (NT) although they frequently express surface proteins. Immunological and genetic methods were used to study 91 NT GBS isolates collected during surveillance studies for invasive disease or colonization in pregnant or non-pregnant women and neonates less than seven days of age. CPS production was upregulated by the addition of glucose and sodium phosphate to Todd-Hewitt broth (THB) and cells were extracted using hot HCl or mutanolysin. Extracts were tested with antisera for specific CPS types Ia, Ib, and II - VIII by double immunodiffusion (DD) in agarose. By mutanolysin extraction, 12 (13.2%) of the 91 isolates were typeable. In contrast, only four of these 12 newly typeable isolates tested positive for CPS with the HCl extracts of cells grown in modified THB. DNA was analyzed by pulsed-field gel electrophoresis (PFGE) using SmaI restriction with NT isolates grouped by protein profile to facilitate analysis. PFGE results of the NT isolates were compared to DNA profiles of typeable isolates and were correlated with the DD results. The DNA profiles of the newly typeable isolates were similar to profiles of isolates with corresponding defined CPS type. Of the remaining 78 NT isolates digested by SmaI, 63 (80.8%) had DNA profiles that resembled those of specific types of GBS. These approaches will be useful for classification of NT isolates in continued epidemiological surveillance associated with GBS vaccine trials.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12139427     DOI: 10.1078/1438-4221-00188

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  9 in total

1.  Molecular characterization of nontypeable group B streptococcus.

Authors:  Srinivas V Ramaswamy; Patricia Ferrieri; Aurea E Flores; Lawrence C Paoletti
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

2.  Clonal analysis of colonizing group B Streptococcus, serotype IV, an emerging pathogen in the United States.

Authors:  Michelle J Diedrick; Aurea E Flores; Sharon L Hillier; Roberta Creti; Patricia Ferrieri
Journal:  J Clin Microbiol       Date:  2010-07-07       Impact factor: 5.948

3.  Phenotypic and genotypic characterization of group B streptococcal isolates in southern Brazil.

Authors:  Jussara K Palmeiro; Libera M Dalla-Costa; Sérgio E L Fracalanzza; Ana C N Botelho; Keite da Silva Nogueira; Mara C Scheffer; Rosângela S L de Almeida Torres; Newton Sérgio de Carvalho; Laura Lúcia Cogo; Humberto M F Madeira
Journal:  J Clin Microbiol       Date:  2010-09-29       Impact factor: 5.948

4.  Effect of transport time, temperature, and concentration on the survival of group B streptococci in amies transport medium.

Authors:  K A Stoner; L K Rabe; S L Hillier
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

5.  DNA macrorestriction analysis of nontypeable group B streptococcal isolates: clonal evolution of nontypeable and type V isolates.

Authors:  Nicole R Amundson; Aurea E Flores; Sharon L Hillier; Carol J Baker; Patricia Ferrieri
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

6.  Use of phenotypic and molecular serotype identification methods to characterize previously nonserotypeable group B streptococci.

Authors:  Fanrong Kong; Lotte Munch Lambertsen; Hans-Christian Slotved; Danny Ko; Hui Wang; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2008-06-18       Impact factor: 5.948

7.  Alpha C protein-specific immunity in humans with group B streptococcal colonization and invasive disease.

Authors:  Pia S Pannaraj; Joanna K Kelly; Marcia A Rench; Lawrence C Madoff; Morven S Edwards; Carol J Baker
Journal:  Vaccine       Date:  2007-12-03       Impact factor: 3.641

8.  Serotype IX, a Proposed New Streptococcus agalactiae Serotype.

Authors:  Hans-Christian Slotved; Fanrong Kong; Lotte Lambertsen; Susanne Sauer; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2007-07-18       Impact factor: 5.948

9.  Latex assay for serotyping of group B Streptococcus isolates.

Authors:  H-C Slotved; J Elliott; T Thompson; H B Konradsen
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.